Kamada Past Earnings Performance

Past criteria checks 4/6

Kamada's earnings have been declining at an average annual rate of -29.7%, while the Biotechs industry saw earnings growing at 22.1% annually. Revenues have been growing at an average rate of 3.4% per year. Kamada's return on equity is 6.2%, and it has net margins of 9.9%.

Key information

-29.7%

Earnings growth rate

-36.6%

EPS growth rate

Biotechs Industry Growth17.0%
Revenue growth rate3.4%
Return on equity6.2%
Net Margin9.9%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Kamada secures $22M extension of Canadian supply tender

Oct 19

Kamada Q2 2022 Earnings Preview

Aug 16

Kamada inks agreement for the distribution of three biosimilar products in Israel

Jan 13

Kamada Looks Cheap AS Takeda Deal Creates Value

Nov 02

Revenue & Expenses Breakdown

How Kamada makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NasdaqGS:KMDA Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24158163514
30 Jun 24155153414
31 Mar 24150123313
31 Dec 2314383212
30 Sep 2315263212
30 Jun 2314633112
31 Mar 23132-23011
31 Dec 22129-22912
30 Sep 22115-102711
30 Jun 22106-122411
31 Mar 22107-72211
31 Dec 21104-2209
30 Sep 211044199
30 Jun 21116121910
31 Mar 21125151711
31 Dec 20133171712
30 Sep 20134211612
30 Jun 20132201612
31 Mar 20134231611
31 Dec 19127221611
30 Sep 19143351610
30 Jun 1912526159
31 Mar 1912426148
31 Dec 1811422148
30 Sep 1810211147
30 Jun 1811013158
31 Mar 1810912159
31 Dec 1710371510
30 Sep 1791-11511
30 Jun 1788-21512
31 Mar 1774-81412
31 Dec 1677-71413
30 Sep 1679-41612
30 Jun 1676-81513
31 Mar 1676-81512
31 Dec 1570-111512
30 Sep 1569-111411
30 Jun 1570-91411
31 Mar 1567-151412
31 Dec 1471-131512
30 Sep 1471-131016
30 Jun 1471-10915
31 Mar 1471-1912
31 Dec 137101011

Quality Earnings: KMDA has high quality earnings.

Growing Profit Margin: KMDA's current net profit margins (9.9%) are higher than last year (4.1%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: KMDA's earnings have declined by 29.7% per year over the past 5 years.

Accelerating Growth: KMDA's earnings growth over the past year (154.7%) exceeds its 5-year average (-29.7% per year).

Earnings vs Industry: KMDA earnings growth over the past year (154.7%) exceeded the Biotechs industry 16.6%.


Return on Equity

High ROE: KMDA's Return on Equity (6.2%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 12:40
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Kamada Ltd. is covered by 8 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Andrew FeinH.C. Wainwright & Co.
Anthony PetroneJefferies LLC
David LewisMorgan Stanley